Where Do Hedge Funds Stand On Apellis Pharmaceuticals, Inc. (APLS)?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Apellis Pharmaceuticals Inc. (APLS)
Get Email AlertsSector: Pharmaceutical Preparations
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Hillhouse Capital Management Lei Zhang | 4,558,029 | $195,585 | -10% | 1.93% |
| 2. | Farallon Capital Thomas Steyer | 2,175,000 | $93,329 | -5% | 0.51% |
| 3. | Cormorant Asset Management Bihua Chen | 1,866,108 | $80,075 | 1.78% | |
| 4. | Baker Bros. Advisors Julian Baker And Felix Baker | 1,674,004 | $71,832 | +87% | 0.31% |
| 5. | VenBio Select Advisor Kurt Von Emster | 1,000,000 | $42,910 | 0.74% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $31.81 | 5,000 | Director | 5,000 | 2020-05-08 | Filing | |
| $37.00 | 540,540 | Large Shareholder | 12,556,342 | 2020-01-13 | Filing | |
| $29.71 | 11,699 | Officer | 11,699 | 2019-08-29 | Filing | |
| $17.00 | 441,176 | Large Shareholder | 12,015,802 | 2019-03-11 | Filing | |
| $19.84 | 40,000 | Large Shareholder | 11,574,626 | 2018-09-21 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $65.00 | 1,000 | Officer | 9,490 | 2021-07-21 | Filing | |
| $62.30 | 1,000 | Officer | 9,490 | 2021-07-15 | Filing | |
| $62.30 | 2,500 | Director | 669,544 | 2021-07-15 | Filing | |
| $64.68 | 500 | Officer | 63,180 | 2021-07-14 | Filing | |
| $65.68 | 250 | Officer | 63,680 | 2021-07-08 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 317,315 | $20,054 | 0.13% | |
| 2. | 235,775 | $14,901 | 0.05% | |
| 3. | 116,628 | $7,371 | 0.06% | |
| 4. | 80,100 | $5,062 | 0% | |
| 5. | 48,457 | $3,062 | 0.01% |
News See All
Is APLS Stock A Buy or Sell?
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns.
Apellis Pharmaceuticals, Inc. (APLS): Hedge Funds Taking Some Chips Off The Table
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Did Hedge Funds Make The Right Call On Apellis Pharmaceuticals, Inc. (APLS) ?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Hedge Funds Are Selling Apellis Pharmaceuticals, Inc. (APLS)
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Hedge Funds Have Never Been This Bullish On Apellis Pharmaceuticals, Inc. (APLS)
We hate to say this but, we told you so.
Apellis Pharmaceuticals, Inc. (APLS) vs. Hedge Fund Favorites in 2019
We are still in an overall bull market and many stocks that smart money investors were piling into surged in 2019.
Hedge Funds Have Never Been This Bullish On Apellis Pharmaceuticals, Inc. (APLS)
Hedge funds are known to underperform the bull markets but that's not because they are bad at investing.
Is Apellis Pharmaceuticals, Inc. (APLS) Going to Burn These Hedge Funds?
It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity.
Hedge Funds Have Never Been This Bullish On Apellis Pharmaceuticals, Inc. (APLS)
Russell 2000 ETF (IWM) lagged the larger S&P 500 ETF (SPY) by nearly 9 percentage points since the end of the third quarter of 2018 as investors worried over the possible ramifications of rising interest...
Billionaire Hedge Funds
